The metabolic syndrome and mind-body therapies: A systematic review

Journal of Nutrition and Metabolism

Volumn 2011, Issue , 2011, Pages

  Anderson, Joel G ^a   Taylor, Ann Gill ^a  

^a UNIVERSITY OF VIRGINIA   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

EID: 80555127814     PISSN: 20900724     EISSN: 20900732     Source Type: Journal    
DOI: 10.1155/2011/276419     Document Type: Review

References (55)

1. World Health Organization, Prevalence of Diabetes Worldwide 2011 2011 Lyon, France World Health Organization
2. Seidell J. C., Obesity, insulin resistance and diabetes-a worldwide epidemic. British Journal of Nutrition 2000 83 supplement 1 S5 S8 2-s2.0-0034109077 (Pubitemid 30319075)
3. Ford E. S., eford@cdc.gov Li C., Zhao G., Prevalence and correlates of metabolic syndrome based on a harmonious definition among adults in the US. Journal of Diabetes 2010 2 3 180 193 10.1111/j.1753-0407.2010.00078.x
4. Rizvi A. A., Type 2 diabetes: epidemiologic trends, evolving pathogenetic concepts, and recent changes in therapeutic approach. Southern Medical Journal 2004 97 11 1079 1087 (Pubitemid 39518700)
5. Perry H. M. III, The endocrinology of aging. Clinical Chemistry 1999 45 8 1369 1376 2-s2.0-0032884043
6. Isomaa B. O., Almgren P., Tuomi T., Forsén B., Lahti K., Nissén M., Taskinen M. R., Groop L., Cardiovascular morbidity and mortality associated with the metabolic syndrome. Diabetes Care 2001 24 4 683 689 2-s2.0-0034837376 (Pubitemid 32893993)
7. Reilly M. P., Rader D. J., The metabolic syndrome: more than the sum of its parts? Circulation 2003 108 13 1546 1551 2-s2.0-0141730248 10.1161/01.CIR.0000088846.10655.E0 (Pubitemid 37187778)
8. Isomaa B., bo.isomaa@fimnet.fi A major health hazard: the metabolic syndrome. Life Sciences 2003 73 19 2395 2411 10.1016/S0024-3205(03)00646-5 (Pubitemid 37101040)
9. Caglayan E., Blaschke F., Takata Y., Hsueh W. A., whsueh@mednet.ucla.edu Metabolic syndrome-interdependence of the cardiovascular and metabolic pathways. Current Opinion in Pharmacology 2005 5 2 135 142 10.1016/j.coph.2005.01.008 (Pubitemid 40378743)
10. Brotman D. J., Girod J. P., The metabolic syndrome: a tug-of-war with no winner. Cleveland Clinic Journal of Medicine 2002 69 12 990 994 2-s2.0-0036927394 (Pubitemid 36041441)
11. DeFronzo R. A., Ferrannini E., Insulin resistance: a multifaceted syndrome responsible for NIDDM, obesity, hypertension, dyslipidemia, and atherosclerotic cardiovascular disease. Diabetes Care 1991 14 3 173 194 2-s2.0-0026021161
12. Laaksonen D. E., Lakka H. M., Niskanen L. K., Kaplan G. A., Salonen J. T., Lakka T. A., Metabolic syndrome and development of diabetes mellitus: application and validation of recently suggested definitions of the metabolic syndrome in a prospective cohort study. American Journal of Epidemiology 2002 156 11 1070 1077 2-s2.0-0036891935 10.1093/aje/kwf145 (Pubitemid 35396938)
13. Sattar N., Gaw A., Scherbakova O., Ford I., O'Reilly D. ST. J., Haffner S. M., Isles C., Macfarlane P. W., Packard C. J., Cobbe S. M., Shepherd J., Metabolic syndrome with and without C-reactive protein as a predictor of coronary heart disease and diabetes in the West of Scotland Coronary Prevention Study. Circulation 2003 108 4 414 419 2-s2.0-0042665536 10.1161/01.CIR. 0000080897.52664.94 (Pubitemid 36935533)
14. Lakka H. M., Laaksonen D. E., Lakka T. A., Niskanen L. K., Kumpusalo E., Tuomilehto J., Salonen J. T., The metabolic syndrome and total and cardiovascular disease mortality in middle-aged men. Journal of the American Medical Association 2002 288 21 2709 2716 2-s2.0-0037021505 10.1001/jama.288.21. 2709 (Pubitemid 35403784)
15. Stas S. N., El-Atat F. A., Sowers J. R., Pathogenesis of hypertension in diabetes. Reviews in Endocrine and Metabolic Disorders 2004 5 3 221 225 2-s2.0-3142629991 10.1023/B:REMD.0000032410.75638.da (Pubitemid 38903579)
16. Wold L. E., Muralikrishnan D., Albano C. B., Norby F. L., Ebadi M., Ren J., Insulin-like growth factor I (IGF-1) supplementation prevents diabetes-induced alterations in coenzymes Q and Q. Acta Diabetologica 2003 40 2 85 90 2-s2.0-0038503639 (Pubitemid 36850924)
17. Wheatcroft S. B., Williams I. L., Shah A. M., Kearney M. T., Pathophysiological implications of insulin resistance on vascular endothelial function. Diabetic Medicine 2003 20 4 255 268 2-s2.0-0037900056 10.1046/j.1464-5491.2003.00869.x (Pubitemid 36606117)
18. Esler M., Rumantir M., Wiesner G., Kaye D., Hastings J., Lambert G., Sympathetic nervous system and insulin resistance: from obesity to diabetes. American Journal of Hypertension 2001 14 11 2-s2.0-0034755215
19. Vitaliano P. P., Scanlan J. M., Zhang J., Savage M. V., Hirsch I. B., Siegler I. C., A path model of chronic stress, the metabolic syndrome, and coronary heart disease. Psychosomatic Medicine 2002 64 3 418 435 2-s2.0-0036113923 (Pubitemid 34556407)
20. Räikkönen K., Matthews K. A., Kuller L. H., The relationship between psychological risk attributes and the metabolic syndrome in healthy women: antecedent or consequence? Metabolism: Clinical and Experimental 2002 51 12 1573 1577 2-s2.0-0036916687 10.1053/meta.2002.36301 (Pubitemid 36018831)
21. Pickering T. G., Phil D., Clemow L., Davidson K., Gerin W., Behavioral cardiology-has its time finally arrived? Mount Sinai Journal of Medicine 2003 70 2 101 112 2-s2.0-0037339121 (Pubitemid 36322201)
22. Björntorp P., Body fat distribution, insulin resistance, and metabolic diseases. Nutrition 1997 13 9 795 803 2-s2.0-0343683306 10.1016/S0899-9007(97)00191-3 (Pubitemid 27382449)
23. Black P. H., Garbutt L. D., Stress, inflammation and cardiovascular disease. Journal of Psychosomatic Research 2002 52 1 1 23 2-s2.0-0036163590 10.1016/S0022-3999(01)00302-6 (Pubitemid 34130239)
24. Chan O., Inouye K., Riddell M. C., Vranic M., Matthews S. G., Diabetes and the hypothalamo-pituitary-adrenal (HPA) axis. Minerva endocrinologica 2003 28 2 87 102 2-s2.0-0042916256
25. von Känel R., Mills P. J., Fainman C., Dimsdale J. E., Effects of psychological stress and psychiatric disorders on blood coagulation and fibrinolysis: a biobehavioral pathway to coronary artery disease? Psychosomatic Medicine 2001 63 4 531 544 2-s2.0-0034928695 (Pubitemid 32695133)
26. Musselman D. L., Betan E., Larsen H., Phillips L. S., Relationship of depression to diabetes types 1 and 2: epidemiology, biology, and treatment. Biological Psychiatry 2003 54 3 317 329 2-s2.0-0141832614 10.1016/S0006-3223(03) 00569-9 (Pubitemid 37267861)
27. Prinz P. N., Sleep and sleep disorders in older adults. Journal of Clinical Neurophysiology 1995 12 2 139 146
28. Åkerstedt T., Nilsson P. M., Sleep as restitution: an introduction. Journal of Internal Medicine 2003 254 1 6 12 2-s2.0-0037707498 10.1046/j.1365-2796.2003.01195.x (Pubitemid 36826643)
29. Meisinger C., christa.meisinger@gsf.de Heier M., Loewel H., Sleep disturbance as a predictor of type 2 diabetes mellitus in men and women from the general population. Diabetologia 2005 48 2 235 241 10.1007/s00125-004-1634-x (Pubitemid 40543295)
30. Newman A. B., Enright P. L., Manolio T. A., Haponik E. F., Wahl P. W., Sleep disturbance, psychosocial correlates, and cardiovascular disease in 5201 older adults: the Cardiovascular Health Study. Journal of the American Geriatrics Society 1997 45 1 1 7 2-s2.0-0031021091 (Pubitemid 27024598)
31. Barnes P. M., Bloom B., Nahin R. L., Complementary and alternative medicine use among adults and children: United States, 2007. National Health Statistics Reports 2009 12 1 23 2-s2.0-59549092689
32. Innes K. E., Bourguignon C., Taylor A. G., Risk indices associated with the insulin resistance syndrome, cardiovascular disease, and possible protection with yoga: a systematic review. Journal of the American Board of Family Practice 2005 18 6 491 519 2-s2.0-29244469607 (Pubitemid 41823887)
33. Sahay B. K., Yoga and diabetes. The Journal of the Association of Physicians of India 1986 34 9 645 648 2-s2.0-0022784701
34. Singh S., Malhotra V., Singh K. P., Madhu S. V., Tandon O. P., Role of Yoga in modifying certain cardiovascular functions in type 2 diabetic patients. Journal of Association of Physicians of India 2004 52 203 206 2-s2.0-13744251950 (Pubitemid 41285669)
35. Xin L., Miller Y. D., Brown W. J., A qualitative review of the role of Qigong in the management of diabetes. Journal of Alternative and Complementary Medicine 2007 13 4 427 433 2-s2.0-34249103130 10.1089/acm.2006.6052 (Pubitemid 46802347)
36. Lee M. S., Chen K. W., Sancier K. M., Ernst E., Qigong for cancer treatment: a systematic review of controlled clinical trials. Acta Oncologica 2007 46 6 717 722 2-s2.0-34547149446 10.1080/02841860701261584 (Pubitemid 47123756)
37. Vera F. M., pvera@uma.es Manzaneque J. M., Maldonado E. F., Carranque G. A., Cubero V. M., Blanca M. J., Morell M., Biochemical changes after a qigong program: lipids, serum enzymes, urea, and creatinine in healthy subjects. Medical Science Monitor 2007 13 12 CR560 CR566 (Pubitemid 350272882)
38. Lee M. S., drmslee@gmail.com Pittler M. H., Guo R., Ernst E., Qigong for hypertension: a systematic review of randomized clinical trials. Journal of Hypertension 2007 25 8 1525 1532 10.1097/HJH.0b013e328092ee18 (Pubitemid 47056554)
39. Paul-Labrador M., Polk D., Dwyer J. H., Velasquez I., Nidich S., Rainforth M., Schneider R., Merz C. N. B., Effects of a randomized controlled trial of transcendental meditation on components of the metabolic syndrome in subjects with coronary heart disease. Archives of Internal Medicine 2006 166 11 1218 1224 2-s2.0-33745039974 10.1001/archinte.166.11.1218 (Pubitemid 43877632)
40. Taylor A. G., Goehler L. E., Galper D. I., Innes K. E., Bourguignon C., Top-down and bottom-up mechanisms in mind-body medicine: development of an integrative framework for psychophysiological research. Explore 2010 6 1 29 41 2-s2.0-72949118144 10.1016/j.explore.2009.10.004
41. Liu X., liuxin@hms.uq.edu.au Miller Y. D., Burton N. W., Brown W. J., A preliminary study of the effects of Tai Chi and Qigong medical exercise on indicators of metabolic syndrome, glycaemic control, health-related quality of life, and psychological health in adults with elevated blood glucose. British Journal of Sports Medicine 2010 44 704 709
42. Khatri D., Mathur K. C., Gahlot S., Jain S., Agrawal R. P., Effects of yoga and meditation on clinical and biochemical parameters of metabolic syndrome. Diabetes Research and Clinical Practice 2007 78 3 e9 e10 2-s2.0-35649024753 10.1016/j.diabres.2007.05.002 (Pubitemid 350030319)
43. Cohen B. E., Chang A. A., Grady D., Kanaya A. M., Restorative yoga in adults with metabolic syndrome: a randomized, controlled pilot trial. Metabolic Syndrome and Related Disorders 2008 6 3 223 229 2-s2.0-51349132315 10.1089/met.2008.0016
44. Anderson J. G., Taylor A. G., Effects of healing touch in clinical practice: a systematic review of randomized clinical trials. Journal of Holistic Nursing. In press 10.1177/0898010110393353
45. Bijlani R. L., rambij@hotmail.com Vempati R. P., Yadav R. K., Ray R. B., Gupta V., Sharma R., Mehta N., Mahapatra S. C., A brief but comprehensive lifestyle education program based on yoga reduces risk factors for cardiovascular disease and diabetes mellitus. Journal of Alternative and Complementary Medicine 2005 11 2 267 274 10.1089/acm.2005.11.267 (Pubitemid 40647161)
46. Vázquez-Vandyck M., Roman S., Vázquez J. L., Huacuja L., Khalsa G., Troyo-Sanromán R., Panduro A., Effect of breathwalk on body composition, metabolic and mood state in chronic hepatitis C patients with insulin resistance syndrome. World Journal of Gastroenterology 2007 13 46 6213 6218 2-s2.0-37849013518 10.3748/wjg.13.6213
47. Altman D. G., Schulz K. F., Moher D., Lepage L., Egger M., Davidoff F., Elbourne D., Gotzsche P. C., Lang T., The revised CONSORT statement for reporting randomized trials: explanation and elaboration. Annals of Internal Medicine 2001 134 8 663 694 2-s2.0-0035901579 (Pubitemid 32322245)
48. Garcia S. F., Cella D., Clauser S. B., Flynn K. E., Lad T., Lai J. S., Reeve B. B., Smith A. W., Stone A. A., Weinfurt K., Standardizing patient-reported outcomes assessment in cancer clinical trials: a patient-reported outcomes measurement information system initiative. Journal of Clinical Oncology 2007 25 32 5106 5112 2-s2.0-36849074114 10.1200/JCO.2007.12. 2341 (Pubitemid 350232291)
49. Patient Reported Outcomes Meas urement Information System (PROMIS),. vol. 2010, http://www.nihpromis.org/Documents/PROMISTheFirstFourYears.pdf
50. Lee M. S., Pittler M. H., Ernst E., Effects of reiki in clinical practice: a systematic review of randomised clinical trials. International Journal of Clinical Practice 2008 62 6 947 954 2-s2.0-43749114972 10.1111/j.1742-1241.2008.01729.x (Pubitemid 351691488)
51. Yang Y., Verkuilen J., Rosengren K. S., Mariani R. A., Reed M., Grubisich S. A., Woods J. A., Effects of a Taiji and Qigong intervention on the antibody response to influenza vaccine in older adults. American Journal of Chinese Medicine 2007 35 4 597 607 2-s2.0-34548154966 10.1142/S0192415X07005090 (Pubitemid 47307698)
52. Lee M. S., Lee M. S., Kim H. J., Moon S. R., Qigong reduced blood pressure and catecholamine levels of patients with essential hypertension. International Journal of Neuroscience 2003 113 12 1691 1701 2-s2.0-0345283159 10.1080/00207450390245306 (Pubitemid 37486299)
53. Bonadonna R., Meditation's impact on chronic illness. Holistic Nursing Practic 2003 17 6 309 319
54. Walton K. G., Schneider R. H., Salerno J. W., Nidich S. I., Psychosocial stress and cardiovascular disease part 3: clinical and policy implications of research on the Transcendental Meditation program. Behavioral Medicine 2005 30 4 173 183 2-s2.0-19844379838 10.3200/BMED.30.4.173-184 (Pubitemid 40762624)
55. Rainforth M. V., Schneider R. H., Nidich S. I., Gaylord-King C., Salerno J. W., Anderson J. W., Stress reduction programs in patients with elevated blood pressure: a systematic review and meta-analysis. Current Hypertension Reports 2007 9 6 520 528 2-s2.0-38049152986 10.1007/s11906-007-0094-3